Synlett 2007(4): 0638-0642  
DOI: 10.1055/s-2007-967944
LETTER
© Georg Thieme Verlag Stuttgart · New York

Ligand-Controlled Intramolecular Carbonylative Cyclization of 1,1-Diethynyl Acetates: New Entry to the Functionalized 4-Cyclopentene-1,3-diones

Keisuke Kato*a, Ryuhei Teraguchia, Shigeo Yamamuraa, Tomoyuki Mochidab, Hiroyuki Akita*a, Tat’yana A. Peganovac, Nikolai V. Vologdinc, Oleg V. Gusevc
a Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan
Fax: +81(474)721825; e-Mail: kkk@phar.toho-u.ac.jp;
b Department of Chemistry, Faculty of Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan
c A. N. Nesmeyanov Institute of Organoelement Compounds of the , Russian Academy of Sciences, Vavilov St.28, 119991 Moscow, Russian Federation
Further Information

Publication History

Received 18 November 2006
Publication Date:
21 February 2007 (online)

Abstract

The carbonylative cyclization of 1,1-diethynyl acetates mediated by Phbox/Pd(TFA)2 afforded a functionalized 4-cyclopentene-1,3-dione as a major product. In the absence of box ligand, a methoxycarbonylated orthoester was obtained predominantly.

11

General Procedure for the Reaction of 1.
A 30 mL two-necked round-bottomed flask, containing a magnetic stirring bar, Pd(TFA)2 (0.015 mmol), ligand (0.0225 mmol), p-benzoquinone (0.6 mmol) and MeOH (5 mL) was fitted with a rubber septum and a three-way stopcock connected to a balloon filled with CO. The apparatus was purged with CO by pumping-filling via the three-way stopcock. To the stirred solution the substrate 1 (0.3 mmol) was added dropwise (3 × 1 mL) via a syringe at 0 °C. After being stirred for a certain period at the appropriate temperature, the mixture was diluted with CH2Cl2 (30 mL), and washed with 2% Na2SO3 aq (30 mL). The organic layers were separated, the aqueous layer was extracted with CH2Cl2 (30 mL), and the combined organic layers were dried with MgSO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel. The fraction eluted with hexane-EtOAc (100:1 to 50:1) afforded 2 and 3 (10:1). The products 2 were separated to give each diastereomer by preparative TLC. The ee of each diastereomer was determined by HPLC using Chiralcel OD column (hexane-EtOH = 150:1, FL = 1.0, for 3a-2) and Chiralcel OF column (hexane-EtOH = 150:1, FL = 0.5, for 3a-1). The relative stereochemistry of 3 was estimated as shown in Figure [2] , based on NOE experiments.
Compound 2a: slightly yellow needles; mp 56 °C. 1H NMR (CDCl3): δ = 2.80-2.84 (2 H, m), 2.89 (2 H, s), 2.95-2.99 (2 H, m), 3.44 (6 H, s), 5.35 (1 H, s), 7.18-7.31 (5 H, m). 13C NMR (CDCl3): δ = 26.5, 34.4, 41.1, 55.5, 98.7, 126.3, 128.4, 128.5, 141.0, 152.3, 161.4, 198.8, 200.3. MS-FAB: m/z = 275 [M+ + H]. IR (KBr): 2933, 1742, 1706 cm-1. Anal. Calcd (%) for C16H18O4: C, 70.06; H, 6.61. Found: C, 69.86; H, 6.57.
Compound 3a-1 (more polar diastereomer): colorless needles; mp 44 °C. 1H NMR (CDCl3): δ = 1.71 (3 H, s), 2.24-2.30 (1 H, m), 2.72 (1 H, s), 2.77-2.90 (2 H, m), 2.95-3.04 (1 H, m), 3.39 (3 H, s), 3.70 (3 H, s), 5.50 (1 H, s), 7.16-7.30 (5 H, m). 13C NMR (CDCl3): δ = 24.1, 30.2, 40.2, 50.3, 51.2, 74.5, 79.5, 81.5, 91.0, 124.2, 126.1, 128.5, 128.5, 141.0, 165.9, 168.0. HRMS (EI): m/z [M+] calcd for C18H20O5: 316.1311; found: 316.1304. IR (KBr): 3269, 2950, 2121, 1720, 1666 cm-1.
Compound 3a-2 (less polar diastereomer): colorless needles; mp 35 °C. 1H NMR (CDCl3): δ = 1.76 (3 H, s), 2.18-2.27 (1 H, m), 2.71 (1 H, s), 2.84-2.92 (1 H, m), 3.03-3.12 (2 H, m), 3.45 (3 H, s), 3.69 (3 H, s), 5.47 (1 H, s), 7.21-7.28 (5 H, m). 13C NMR (CDCl3): δ = 24.0, 30.5, 39.3, 49.6, 51.2, 74.6, 80.0, 80.3, 91.1, 124.5, 126.1, 128.5, 128.5, 141.2, 166.0, 167.4. HRMS (EI): m/z [M+] calcd for C18H20O5: 316.1311; found 316.1318. IR (KBr): 3246, 2949, 2113, 1708, 1658 cm-1.
Compound 2b: slightly yellow oil. 1H NMR (CDCl3): δ = 0.88 (3 H, t, J = 6.8 Hz), 1.22-1.56 (12 H, m), 2.65 (2 H, t, J = 7.8 Hz), 2.89 (2 H, s), 3.45 (6 H, s), 5.36 (1 H, s). 13C NMR (CDCl3): δ = 14.1, 22.7, 24.4, 28.4, 29.1, 29.2, 30.0, 31.8, 41.2, 55.5, 98.8, 151.7, 162.8, 198.9, 200.7. HRMS (EI): m/z [M+] calcd for C16H26O4: 282.1831; found: 282.1829. IR (neat): 2927, 1745, 1706 cm-1.
Compound 3b-1 (more polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.88 (3 H, t, J = 8.0 Hz), 1.22-1.35 (10 H, m), 1.39-1.52 (1 H, m), 1.57-1.71 (1 H, m), 1.68 (3 H, s), 1.99-2.06 (1 H, m), 2.41-2.49 (1 H, m), 2.66 (1 H, s), 3.36 (3 H, s), 3.70 (3 H, s), 5.47 (1 H, s). 13C NMR (CDCl3): δ = 14.1, 22.7, 23.8, 24.1, 29.2, 29.3, 29.4, 31.9, 38.4, 50.3, 51.1, 74.1, 79.9, 82.1, 90.6, 124.0, 165.9, 168.4. HRMS (EI): m/z [M+] calcd for C18H28O5: 324.1937; found: 324.1924. IR (KBr): 3281, 2927, 2120, 1723, 1657 cm-1.
Compound 3b-2 (less polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.88 (3 H, t, J = 7.0 Hz), 1.22-1.40 (10 H, m), 1.49-1.62 (1 H, m), 1.68-1.78 (1 H, m), 1.72 (3 H, s), 1.93-2.00 (1 H, m), 2.64-2.72 (1 H, m), 2.65 (1 H, s), 3.31 (3 H, s), 3.70 (3 H, s), 5.45 (1 H, s). 13C NMR (CDCl3): δ = 14.1, 22.7, 24.1, 24.1, 29.2, 29.4, 29.5, 31.9, 37.4, 49.5, 51.1, 74.2, 80.4, 80.8, 90.8, 124.3, 166.0, 167.9. HRMS (EI): m/z [M+] calcd for C18H28O5: 324.1937; found: 324.1965. IR (KBr): 3296, 2931, 2119, 1725, 1657 cm-1.
Compound 2c: colorless oil. 1H NMR (CDCl3): δ = 0.90 (3 H, t, J = 7.2 Hz), 1.31-1.37 (4 H, m), 1.47-1.54 (2 H, m), 2.65 (2 H, t, J = 7.8 Hz), 2.89 (2 H, s), 3.45 (6 H, s), 5.37 (1 H, s). 13C NMR (CDCl3): δ = 13.9, 22.3, 24.3, 28.1, 32.1, 41.2, 55.5, 98.7, 151.7, 162.8, 199.0, 200.7. HRMS (EI): m/z [M+] calcd for C13H20O4: 240.1362; found: 240.1352. IR (neat): 2932, 1745, 1706 cm-1.
Compound 3c-1 (more polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.89 (3 H, t, J = 7.2 Hz), 1.29-1.37 (4 H, m), 1.44-1.52 (1 H, m), 1.58-1.66 (1 H, m), 1.69 (3 H, s), 1.98-2.06 (1 H, m), 2.40-2.49 (1 H, m), 2.67 (1 H, s), 3.36 (3 H, s), 3.70 (3 H, s), 5.47 (1 H, s). 13C NMR (CDCl3): δ = 13.9, 22.4, 23.4, 24.0, 31.4, 38.3, 50.2, 51.1, 74.1, 79.8, 82.0, 90.6, 124.0, 165.9, 168.4. HRMS (EI): m/z [M+] calcd for C15H22O5: 282.1467; found: 282.1419. IR (KBr): 3248, 2952, 2122, 1710, 1656 cm-1. Anal. Calcd for C15H22O5: C, 63.83; H, 7.85. Found: C, 63.71; H, 7.89.
Compound 3c-2 (less polar diastereomer): colorless oil. 1H NMR (CDCl3): δ = 0.90 (3 H, t, J = 6.8 Hz), 1.31-1.37 (4 H, m), 1.51-1.61 (1 H, m), 1.68-1.79 (1 H, m), 1.73 (3 H, s), 1.92-2.00 (1 H, m), 2.65-2.72 (1 H, m), 2.65 (1 H, s), 3.31 (3 H, s), 3.70 (3 H, s), 5.45 (1 H, s). 13C NMR (CDCl3): δ = 13.9, 22.5, 23.7, 24.0, 31.5, 37.3, 49.5, 51.1, 74.2, 80.4, 80.8, 90.8, 124.3, 166.0, 167.9. HRMS (EI): m/z [M+] calcd for C15H22O5: 282.1467; found: 282.1466. IR (KBr): 3298, 2952, 2120, 1723, 1658 cm-1.
Compound 2d: colorless oil. 1H NMR (CDCl3): δ = 1.41 (3 H, s), 2.93 (2 H, s), 3.09 (2 H, s), 3.49 (6 H, s), 3.91-3.99 (4 H, m), 5.39 (1 H, s). 13C NMR (CDCl3): δ = 25.2, 32.7, 41.6, 56.1, 64.8, 100.1, 109.3, 153.1, 156.5, 198.5, 199.9. HRMS (EI): m/z [M+] calcd for C13H18O6: 270.1103; found: 270.1109. IR (neat): 3438, 2937, 1750, 1708 cm-1.
Compound 3d: inseparable mixture of diastereomers (ratio = 2.4:1); colorless oil. 1H NMR (CDCl3): δ (major diastereomer) = 1.56 (3 H, s), 1.73 (3 H, s), 2.44 (1 H, d, J = 15.2 Hz), 2.71 (1 H, s), 2.96 (1 H, d, J = 15.2 Hz), 3.38 (3 H, s), 3.70 (3 H, s), 3.87-4.08 (4 H, m), 5.46 (1 H, s). 1H NMR (CDCl3): δ = (minor diastereomer) = 1.61 (3 H, s), 1.76 (3 H, s), 2.18 (1 H, d, J = 14.8 Hz), 2.72 (1 H, s), 3.32 (1 H, d, J = 14.8 Hz), 3.35 (3 H, s), 3.70 (3 H, s), 3.87-4.08 (4 H, m), 5.43 (1 H, s). 13C NMR (CDCl3): δ (major diastereomer) = 23.7, 25.9, 44.9, 50.4, 51.1, 64.3, 64.5, 74.2, 79.1, 79.9, 90.1, 108.2, 124.5, 165.9, 168.8. 13C NMR (CDCl3): δ (minor diastereomer) = 24.1, 25.5, 43.9, 49.6, 51.1, 64.4, 64.5, 74.7, 77.9, 80.1, 90.3, 108.5, 125.2, 165.9, 168.5. HRMS (EI): m/z [M+] calcd for C15H20O7: 312.1209; found: 312.1191. IR (KBr): 3248, 2907, 2117, 1707, 1650 cm-1. Compound 2e: colorless oil. 1H NMR (CDCl3): δ = 2.88 (2 H, s), 3.45 (6 H, s), 4.04 (2 H, s), 5.43 (1 H, s), 7.17-7.35 (5 H, m). 13C NMR (CDCl3): δ = 30.0, 41.3, 55.6, 98.7, 126.7, 128.5, 129.6, 136.6, 151.8, 159.6, 198.8, 200.3. HRMS (EI): m/z [M+] calcd for C16H16O4: 260.1049; found: 260.1054. IR (KBr): 2935, 1747, 1706 cm-1. Compound 3e-1 (more polar diastereomer): colorless needles; mp 64 °C. 1H NMR (CDCl3): δ = 1.23 (3 H, s), 2.70 (1 H, s), 3.33 (3 H, s), 3.54 (1 H, d, J = 14.0 Hz), 3.78 (3 H, s), 3.81 (1 H, d, J = 14.0 Hz), 5.54 (1 H, s), 7.23-7.30 (5 H, m). 13C NMR (CDCl3): δ = 23.3, 43.9, 50.4, 51.3, 74.7, 80.2, 82.1, 91.3, 124.4, 127.4, 128.0, 131.3, 134.6, 166.1, 167.6 MS (EI): m/z = 302 [M+]. IR (KBr): 3262, 2115, 1716, 1657 cm-1. Anal. Calcd for C17H18O5: C, 67.54; H, 6.00. Found: C, 67.63; H, 6.05.
Compound 3e-2 (less polar diastereomer): colorless needles; mp 67 °C. 1H NMR (CDCl3): δ = 1.70 (3 H, s), 2.65 (1 H, s), 3.05 (3 H, s), 3.61 (1 H, d, J = 14.0 Hz), 3.77 (3 H, s), 3.87 (1 H, d, J = 14.0 Hz), 5.55 (1 H, s), 7.25-7.38 (5 H, m). 13C NMR (CDCl3): δ = 24.1, 42.7, 49.5, 51.3, 75.2, 80.3, 80.4, 91.5, 124.5, 127.2, 128.0, 131.2, 135.0, 166.2, 167.2. MS (EI): m/z = 302 [M+]. IR (KBr): 3262, 2117, 1716, 1651 cm-1. Anal. Calcd for C17H18O5: C, 67.54; H, 6.00. Found: C, 67.19; H, 6.02.

Figure 2